FDA Inspection 789470 — Medart A /S

Medart A /S — FEI 3005616124

The FDA completed an inspection of Medart A /S on June 1, 2012 in Hvidovre. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 12 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
June 1, 2012
Fiscal Year
2012
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Hvidovre (Denmark)

Citations

IDCFRDescription
1471321 CFR 820.198(a)Lack of or inadequate complaint procedures
235021 CFR 820.25(b)Training - Lack of or inadequate procedures
243021 CFR 820.30(b)Design plans - Lack of or inadequate
260421 CFR 820.30(e)Design review - Lack of or inadequate procedures
265021 CFR 820.30(f)Design verification - Lack of or inadequate procedures
310121 CFR 820.30(g)Design validation- Lack of or inadequate procedures
313021 CFR 820.100(a)Lack of or inadequate procedures
323321 CFR 820.72(a)Calibration, Inspection, etc. Procedures Lack of or Inadequ
326221 CFR 820.250(a)Statistical techniques - Lack of or inadequate procedures
366621 CFR 820.20(c)Management review - Lack of or inadequate procedures
367821 CFR 820.30(g)Design Validation - Risk analysis not performed/inadequate
63121 CFR 803.17(a)(1)Lack of System for Event Evaluations